IFNG and colorectal carcinoma: LAK cells expressing high levels of the immune checkpoint receptor PD1 on a subset of cells (about 10%) were co-cultured with CRC organoids from MSS+ CRC patients either before or after treatment with IFNγ or a peroxisome proliferator-activated receptor-gamma (PPARγ) agonist [230].